99m Tc‐SNW‐1 Nanoparticle Labeling and Its Biodistribution/Pathological Evaluations
Journal of Labelled Compounds and Radiopharmaceuticals · 2025-07 · 68 (9-10)
DOI: 10.1002/jlcr.4160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, online erschienen am 07.08.2025. Verfasst von Setareh Derakhshan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Nanoparticles, Technetium, Organotechnetium Compounds, Radiopharmaceuticals. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
This study aimed to evaluate the targeted diagnostic imaging and therapeutic applications of SNW‐1 nanoparticles. The nanoparticles were synthesized using microwave technique and characterized in terms of size, zeta potential, morphology, and chemical structure. The results demonstrated that the quasispherical and planar nanoparticles with the size of 370.4 nm and zeta potential of 0.4 mV were synthesized. Then, the nanoparticles were labeled with technetium‐99m, and their in vivo biodistribution was assessed. Based on the results, the highest accumulation of the nanoparticles was observed in the bladder, liver, kidney, and heart tissues of the rabbits, respectively, while in the rat, the highest accumulation was observed in the liver, bladder, and heart tissues, respectively. In the rabbits, on average, the accumulation of the nanoparticles in the bladder was 7.4‐, 8.7‐, and 44.1‐fold higher than that of the liver, kidney, and heart, respectively, while in the rat, the accumulation of the nanoparticles in the liver was 8.4‐ and 20.3‐fold higher compared to that of the bladder and heart, respectively. The high bladder accumulation of the SNW‐1 nanoparticles can be indicated by their high clearance, making them especially appropriate for kidney imaging and therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Vaccine Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Echocardiography Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Department of Chemical Medicine, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- Ministry of Health and Medical Education, Tehran, Iran.
ORCID-Profile: Mehdi Shafiee Ardestani, Tahereh Zadeh Mehrizi
Zitieren
APA
Derakhshan, S., Shafiee Ardestani, M., Zadeh Mehrizi, T., Bitarafan-Rajabi, A., Jokar, S., Pirali Hamedani, M., & Mirzaei, M. (2025). 99m Tc‐SNW‐1 Nanoparticle Labeling and Its Biodistribution/Pathological Evaluations. Journal of Labelled Compounds and Radiopharmaceuticals, 68(9-10). https://doi.org/10.1002/jlcr.4160
Vancouver
Derakhshan S, Shafiee Ardestani M, Zadeh Mehrizi T, Bitarafan-Rajabi A, Jokar S, Pirali Hamedani M, et al. 99m Tc‐SNW‐1 Nanoparticle Labeling and Its Biodistribution/Pathological Evaluations. Journal of Labelled Compounds and Radiopharmaceuticals. 2025;68(9-10). doi:10.1002/jlcr.4160
BibTeX
@article{Derakhshan2025,
author = {Derakhshan, Setareh and Shafiee Ardestani, Mehdi and Zadeh Mehrizi, Tahereh and Bitarafan-Rajabi, Ahmad and Jokar, Safura and Pirali Hamedani, Morteza and Mirzaei, Mehdi},
title = {99m Tc‐SNW‐1 Nanoparticle Labeling and Its Biodistribution/Pathological Evaluations},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2025},
volume = {68},
number = {9-10},
doi = {10.1002/jlcr.4160}
}
EUVIMED